in this issue
Regions :: North America :: U.S.
Senate Approves FDA Safety and Innovation Act
7:35 AM MDT | May 29, 2012 | Deepti Ramesh
The U.S. Senate, on May 24, 2012, approved the Food and Drug Administration Safety and Innovation Act (S. 2516), which aims to improve safety in the U.S. drug supply chain. The bulk pharmaceutical task force (BPTF; Washington), an affiliate of Socma, has commended the Senate for approving the Safety and Innovation Act. BPTF is an industry organization for U.S. manufacturers of active pharmaceutical ingredients (APIs), pharma intermediates, and excipients. The legislation reauthorizes FDA user fee programs. The previously announced generic drug user fee program...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee